Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

Nasal administration of influenza vaccine has the potential to facilitate influenza control and prevention. However, when administered intranasally (i.n.), commercially available inactivated vaccines only generate systemic and mucosal immune responses if strong adjuvants are used, which are often as...

Descripción completa

Detalles Bibliográficos
Autores principales: Saluja, Vinay, Amorij, Jean P., van Roosmalen, Maarten L., Leenhouts, Kees, Huckriede, Anke, Hinrichs, Wouter L. J., Frijlink, Henderik W.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844513/
https://www.ncbi.nlm.nih.gov/pubmed/20058113
http://dx.doi.org/10.1208/s12248-009-9168-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844513/
https://www.ncbi.nlm.nih.gov/pubmed/20058113
http://dx.doi.org/10.1208/s12248-009-9168-2

Ejemplares similares